Effects of Methylphenidate on Mobility, Cognition and Fatigue in Multiple Sclerosis: A Pilot Randomized Controlled Trial (P3.341)

Conclusions:Although limited by small sample size, this study suggests that methylphenidate up to 30mg bid is likely less effective than placebo for improving mobility, cognition or fatigue in MS.Study Supported by: National Multiple Sclerosis SocietyDisclosure: Dr. Cameron has received personal compensation for activities with ReWalk and Adamas as a consultant.
Source: Neurology - Category: Neurology Authors: Tags: Quality of Life, Symptoms and Symptomatic Therapy, Comorbidity, and Patient Reported Outcomes in Multiple Sclerosis Source Type: research